Search Results 321-330 of 16271 for monoclonal antibody

  1. Oncology (Medical) - Clinical trials

    Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, ...

  2. Skin Cancer Clinical Trials - Mayo Clinic Research

    Vemurafenib and cobimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as ...

  3. Science Saturday: Collaborative study discovers new disease behind patient's recurring blood clots

    It occurs when an individual produces monoclonal antibodies (mAbs) to platelet factor 4 (PF4) leading to blood clots and low platelet counts. "MGTS is a ...

  4. Hematology - Clinical trials

    ... monoclonal antibody, and compare them with clinical outcomes. A Study to ... The purpose of this study is to evaluate the immune and hematopoietic compartments in ...

  5. Pozelimab-bbfg (intravenous route, subcutaneous route) - Mayo Clinic

    This medicine is a monoclonal antibody that works on the immune system. This medicine is to be given only by or under the direct supervision of your doctor ...

  6. Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma - Mayo Clinic

    Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  7. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-CTLA4 monoclonal antibody).

  8. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...

  9. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation ...

  10. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...